Glen Rennie

Glen Rennie

Company: Cedilla Therapeutics

Job title: Principal Scientist


Targeting the Hippo Pathway with Conditional Modulation of TEAD Activity 9:30 am

Mechanistic insights into the allosteric inhibition of TEAD How Cedilla is using multiple methodologies to screen for inhibitors with distinct mechanisms of action Opportunities for treating cancers with Hippo pathway dysregulationRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.